High Performance Medical Plastics Market worth $1,242 million by 2025 | Key players operating in the market include Solvay SA, SABIC, EvonikIndustries AG, Arkema SA, Ensinger

According to recent market research "High Performance Medical Plastics Market by Type (FP, HPPA, PAEK, PPS, PEI), Application (Medical Supplies, Medical Equipment & Tools, Drug Delivery, Prosthesis & Implants, Therapeutic System), Region - Global Forecast to 2026", size is projected to grow from USD 851 million in 2021 to USD 1,242 million by 2026, at a CAGR of 7.8% during the forecast period 2021 to 2026. Increasing use of high-performance medical plastics in advanced medical technology in implants, precision medicines, smart inhalers, artificial organs, customized minimally invasive devices, and robotic assistance in surgical operations are propelling the demand for high performance medical plastics across the globe.

Browse 124 market data Tables and 46 Figures spread through 209 Pages and in-depth TOC on "High Performance Medical Plastics Market - Global Forecast to 2026"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/high-performance-medical-plastics-market-146073142.html

By type, the FP segment accounted for the largest market share in 2020. Various types of FP such as Polytetrafluoroethylene (PTFE), Polyvinylidene Fluoride (PVDF), and Fluorinated Ethylene Propylene (FEP) are widely used in various applications. Surgical equipment, such as handles and grips for instrumentation, sizing trials for knee and hip replacement, fixation devices, endoscopic housings, and eyepieces, are manufactured using high performance fluoropolymers, owing to their high chemical resistance. These FPs have greater thermal stability and temperature resistance property and are, thus, widely used to manufacture parts for X-ray and Magnetic Resonance Imaging (MRI) devices. The larger share of the FP segment can be attributed to the increase in demand for PTFE and FEP in medical applications such as components of medical devices, surgical instruments, and therapeutic systems, among others.

By application, the medical equipment & tools segment accounted for the largest share of the high-performance medical plastics market in 2020. The larger market share can be attributed to the increase in demand for 3D printing high performance plastics in medical devices. This segment covers medical equipment & tools, such as components of medical devices, handles, and grips for instrumentation, sizing trials for knee and hip replacement, fixation devices, endoscopic housings, dental tools, and equipment such as key parts for dialysis machine and cardiovascular surgery that are manufactured using high performance plastics such as PEEk, PEI, PPSU, PEKK, PAI, among others.

For more Details Speak to Our Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=146073142

The global high performance medical plastics market size is projected to grow from USD 851 million in 2021 to USD 1,242 million by 2026, at a CAGR of 7.8% during the forecast period 2021 to 2026. The growing use of advanced medical technologies, such as 3D printed implants and customized devices is one of the major factor propelling the growth of the high performance medical plastics market.

Solvay SA (Belgium), SABIC (UAE), Mitsubishi Chemical Corporation (Japan), EvonikIndustries AG (Germany), Arkema SA (France), Ensinger (Germany), Victrex PLC (UK), Rochling SE & Co. AG (Germany), Raumedic AG (Germany), The Chemours Company (US), DuPont (US), Saint-Gobain Performance Plastics (France), Celanese Corporation (US), Trelleborg (Sweden) and Tekni-Plex (US) are some of the leading players operating in the high-performance medical plastics market. These players have adopted the strategies of acquisitions and partnerships to enhance their position in the market.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146073142

Solvay SA is the largest company in the global high performance medical plastics market. High performance plastics are a part of the materials business segment of the company. Solvay SA operates through 428 subsidiaries in 64 countries of Europe, North America, Latin America, and Asia-Pacific. The company has 119 operational facilities worldwide. As a global leader in materials, chemicals, and solutions, Solvay brings advancements in planes, cars, batteries, smart and medical devices, and water and air treatment, to solve critical industrial, social, and environmental challenges. Solvay SA, in December 2020 entered into a partnership with PrinterPrezz (US) to develop 3D printing Selective Laser Sintering (SLS) solutions for implants and other medical devices using high performance polymers.

Another important player in the high-performance medical plastics market is EvonikIndustries AG. The company has vast experience in manufacturing high performance medical plastics and a broad product portfolio, huge production capacity, and sales, logistics, and technical service network. Evonikindustry has a dedicated section for medical plastic division and products like VESTAKEEP, VESTAMID and TRAGOMID care have application in dental applications, body implants and medical devices. Evonikindustry is one of the world leaders in specialty chemicals. Evonikindustry goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. The company has done major acquisitions and joint ventures with companies like Durect Corporation and Wynka Silicon for increasing its high-performance medical plastics market.

Contact:

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: newsletter@marketsandmarkets.com
Press Release: https://www.marketsandmarkets.com/PressReleases/high-performance-medical-plastics.asp
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/high-performance-medical-plastics-market.asp

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.